Project/Area Number |
13671190
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Metabolomics
|
Research Institution | Osaka University |
Principal Investigator |
YAMAGATA Kazuya Osaka University Graduate School of Medicine, Assistant Professor, 医学系研究科, 助手 (70324770)
|
Co-Investigator(Kenkyū-buntansha) |
OKITA Kohei Osaka University Graduate School of Medicine, Medical staff, 医学部附属病院, 医員(臨床研究)
MIYAGAWA Junnichiro Osaka University Graduate school of Medicine, Lecturer, 医学系研究科, 講師 (00127721)
上中 理香子 大阪大学, 医学部・附属病院, 医員
|
Project Period (FY) |
2001 – 2002
|
Project Status |
Completed (Fiscal Year 2002)
|
Budget Amount *help |
¥3,300,000 (Direct Cost: ¥3,300,000)
Fiscal Year 2002: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 2001: ¥2,400,000 (Direct Cost: ¥2,400,000)
|
Keywords | diabetes mellitus / maturity-onset diabetes of the young (MODY) / insulin / transcription factor / HNF-1 / growth / development / IGF-1 |
Research Abstract |
Maturity-onset diabetes of the young (MODY) is a monogenic form of type 2 diabetes. We have shown that heterozygous mutations in genes encoding hepatocyte nuclear factor (HNF)-1α, HNF-1β and HNF-4α cause MODY (Nature 1996a, Nature 1996b and Nature Genet. 1997). In the present study, we first examined whether HNF is involved in the development and the gowth of pancreatic β-cells. Immunohistochemical analysis showed that HNF1α is expressed in all kinds of endocrine cells (α-cells, β-cells, δ-cells and Ppcells) in mouse pancreas from the developmental stage. Double staining of pancreas for HNF-1α and various transcription factors (PDX-1, Pax6, Isl1, and Nkx2.2) suggested that HNF-1α expression occurs after the expression of PDX-1, Pax6, Isl1, and Nkx2.2 (Diabetologia 2002). P291fsinsC-HNF-1α is a most common mutation identified in human MODY3 patients and this mutation functions as dominant negative (Diabetes 1998). Transgenic mice overexpressing P291 fsinsC-HNF-1α mutant in pancreatic β-cells developed diabetes with reduced β-cell number and β-cell growth (Diabetes 2002a). To elucidate the mechanism, we overexpressed the same mutant in INS-1 cells using Tet-On system under the control of doxycyclin (Diabetes 2002b). Cell growth of the INS-1 cells overexpressing P291fsinsC-HNF-1α was impaired with the reduced expression of IGF-1. The addition of IGF-1 rescued the reduced cell growth of P291fsinsC-HNF-1α expressing INS-1 cells. These data suggest that HNF-1α is involved in the growth and the development of pancreatic β-cells.
|